BRIAN WEINSTEIN: Open Payments
NPI 1952700841 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 8 payments from 6 companies in 2025. Trend: 2023 $151 · 2024 $123 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 1 | $128 |
| Lilly USA, LLC | 3 | $60 |
| Journey Medical Corporation | 1 | $28 |
| ABBVIE INC. | 1 | $27 |
| Almirall LLC | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: NEMLUVIO, EBGLYSS, SKYRIZI, Klisyri, TALTZ, OTEZLA.
Industry payments across CO — which companies pay providers there.
